Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
To evaluate 18F-AV-133 imaging of the pancreas in patients with early type 2 diabetes, late
type 2 diabetes, subjects with pre-diabetes and in healthy overweight/obese control subjects.
These subjects will also be evaluated for beta-cell function as measured by the insulin and
C-peptide response to a challenge with intravenous arginine under basal and glucose enhanced
conditions.